Time trend of ASDR and ASMR for hypertension -related AA by sex globally and acorss diverse SDI region from 1990 to 2021. by Guanghui Yu (423945)

Positive stool samples by pathogen and study sites. by Amete Mihret Teshale (12072758)

Socio-demographic and clinical characteristics of participants by study site. by Amete Mihret Teshale (12072758)

The relationship between age-standardized DALYs due to hypertension-induced AA and the SDI. by Guanghui Yu (423945)

Comparison of markers of aging among PHIVAYA groups and healthy controls. by Maria Raffaella Petrara (4446358)

Stress-strain curves of freeze-thaw cycling sandstone under different loading rates. by Wenyu Lv (20139458)

The trend of ASDR for hypertension-related AA in global age groups from 2022 to 2050 predicted using the Bayesian age-period-cohort (BAPC) model. by Guanghui Yu (423945)

Comparison of circulating biomarkers among PHIVAYA subgroups. by Maria Raffaella Petrara (4446358)

Comparison of HIV-DNA and cell-associated HIV-RNA levels among PHIVAYA subgroups. by Maria Raffaella Petrara (4446358)

Comparison of immune and cellular markers of aging among PHIVAYA subgroups. by Maria Raffaella Petrara (4446358)

Gaussian model fitted of the number of dogs detections of SARS-CoV-2, depending on the cycle threshold (Ct) values of RT-qPCR tests for SARS-CoV-2. by Víctor M. Vidal-Martínez (18707335)

Schematic pathogenetic pathway of how persistent HIV reservoir may lead to premature aging and precocious onset of aging-related comorbidities. by Maria Raffaella Petrara (4446358)

Calibration of standards. by Asif Khan (1740271)

“…<i>erecta</i> may be a promising medicinal agent for reducing the risk and progression of Parkinson’s disease.…”

Appearance of standards under UV 365 nm. by Asif Khan (1740271)

“…<i>erecta</i> may be a promising medicinal agent for reducing the risk and progression of Parkinson’s disease.…”

HPLC-Chromatogram of methanol fraction. by Asif Khan (1740271)

“…<i>erecta</i> may be a promising medicinal agent for reducing the risk and progression of Parkinson’s disease.…”

Effects of <i>B</i>.<i>erecta</i> on kidney profile test. by Asif Khan (1740271)

“…<i>erecta</i> may be a promising medicinal agent for reducing the risk and progression of Parkinson’s disease.…”

Effects of <i>B</i>.<i>erecta</i> on Morris water maze test. by Asif Khan (1740271)

“…<i>erecta</i> may be a promising medicinal agent for reducing the risk and progression of Parkinson’s disease.…”

Effects of <i>B</i>.<i>erecta</i> on liver profile test. by Asif Khan (1740271)

“…<i>erecta</i> may be a promising medicinal agent for reducing the risk and progression of Parkinson’s disease.…”

Antibody reagent list. by Helena Saura Martinez (22305113)

“…In <i><i>T. bryosalmonae</i></i> exposed animals, parasite concentration increased significantly over time. Moreover, a proportional increase in IgM⁺ B cells and a proportional decrease in myeloid cells over time was observed. …”

Age-standardized prevalence rates of gynecological diseases across 204 countries and territories in 2021. by Xiaofeng He (2618752)